CanSino Biologics, Inc. Class H's market cap is currently HK$10.98B. The company's EPS TTM is HK$-3.153; its P/E ratio is ―; CanSino Biologics, Inc. Class H is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$-0.16. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 345.18M	¥ 1.03B	¥ 4.30B	¥ 18.54M	¥ 2.28M
Gross Profit	¥ -876.02M	¥ -186.61M	¥ 3.00B	¥ 4.74M	¥ 2.14M
Operating Income	¥ -2.04B	¥ -1.37B	¥ 1.91B	¥ -440.32M	-
EBITDA	¥ -1.65B	¥ -1.03B	¥ 1.98B	¥ -402.97M	¥ -204.90M
Net Income	¥ -1.48B	¥ -964.76M	¥ 1.91B	¥ -358.49M	¥ -153.11M
Balance Sheet
Cash & Short-Term Investments	¥ 4.12B	¥ 5.95B	¥ 7.78B	¥ 5.11B	¥ 754.79M
Total Assets	¥ 9.32B	¥ 11.47B	¥ 11.87B	¥ 6.75B	¥ 1.78B
Total Debt	¥ 2.70B	¥ 2.70B	¥ 1.37B	¥ 142.54M	¥ 166.80M
Net Debt	¥ 653.34M	¥ -694.19M	¥ -4.08B	¥ -4.30B	¥ -35.65M
Total Liabilities	¥ 4.03B	¥ 4.22B	¥ 3.33B	¥ 677.22M	¥ 313.98M
Stockholders' Equity	¥ 5.27B	¥ 6.75B	¥ 8.00B	¥ 6.07B	¥ 1.47B
Cash Flow
Free Cash Flow	¥ -1.53B	¥ -2.96B	¥ 811.42M	¥ -740.16M	¥ -287.14M
Operating Cash Flow	¥ -916.25M	¥ -1.89B	¥ 2.01B	¥ -469.39M	¥ -170.19M
Investing Cash Flow	¥ -449.65M	¥ -1.19B	¥ -2.53B	¥ -182.71M	¥ -797.77M
Financing Cash Flow	¥ -7.58M	¥ 854.60M	¥ 1.56B	¥ 4.94B	¥ 1.09B

Currency in CNY

CanSino Biologics, Inc. Class H Earnings and Revenue History

Income Statement >

CanSino Biologics, Inc. Class H Debt to Assets

Balance Sheet >

CanSino Biologics, Inc. Class H Cash Flow

Cash Flow >

CanSino Biologics, Inc. Class H Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing